These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structure-based glycoconjugate vaccine design: The example of Group B Streptococcus type III capsular polysaccharide. Carboni F; Adamo R Drug Discov Today Technol; 2020 Dec; 35-36():23-33. PubMed ID: 33388125 [TBL] [Abstract][Full Text] [Related]
7. The preparation of neoglycoconjugates containing inter-saccharide phosphodiester linkages as potential anti-Leishmania vaccines. Routier FH; Nikolaev AV; Ferguson MA Glycoconj J; 1999 Dec; 16(12):773-80. PubMed ID: 11133017 [TBL] [Abstract][Full Text] [Related]
8. New strategies in vaccination against fungal infections. Polonelli L; Poulain D; Cole GT; Conti S; Elad D; Gerloni M; Kirkland T; Matthews R; Segal E; Wyckoff E J Med Vet Mycol; 1994; 32 Suppl 1():105-12. PubMed ID: 7536837 [No Abstract] [Full Text] [Related]
9. Adjuvants and delivery systems for antifungal vaccines: current state and future developments. Portuondo DL; Ferreira LS; Urbaczek AC; Batista-Duharte A; Carlos IZ Med Mycol; 2015 Jan; 53(1):69-89. PubMed ID: 25362733 [TBL] [Abstract][Full Text] [Related]
11. Fungal vaccines: real progress from real challenges. Cassone A Lancet Infect Dis; 2008 Feb; 8(2):114-24. PubMed ID: 18222162 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine. Wu X; Lipinski T; Carrel FR; Bailey JJ; Bundle DR Org Biomol Chem; 2007 Nov; 5(21):3477-85. PubMed ID: 17943207 [TBL] [Abstract][Full Text] [Related]
13. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease. Wright K; Guerreiro C; Laurent I; Baleux F; Mulard LA Org Biomol Chem; 2004 May; 2(10):1518-27. PubMed ID: 15136809 [TBL] [Abstract][Full Text] [Related]
14. Broadly protective semi-synthetic glycoconjugate vaccine against pathogens capable of producing poly-β-(1→6)-N-acetyl-d-glucosamine exopolysaccharide. Gening ML; Pier GB; Nifantiev NE Drug Discov Today Technol; 2020 Dec; 35-36():13-21. PubMed ID: 33388124 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Based Mycosis Vaccine. Zubair S; Azhar A; Khan N; Ahmad E; Ajmal M; Owais M Methods Mol Biol; 2017; 1625():169-211. PubMed ID: 28584991 [TBL] [Abstract][Full Text] [Related]
16. Induced humoral immunity and vaccination against major human fungal pathogens. Casadevall A; Feldmesser M; Pirofski LA Curr Opin Microbiol; 2002 Aug; 5(4):386-91. PubMed ID: 12160857 [TBL] [Abstract][Full Text] [Related]
17. Fungal vaccines and immunotherapeutics. Santos E; Levitz SM Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a019711. PubMed ID: 25368016 [TBL] [Abstract][Full Text] [Related]
18. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines]. Mulard L Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349 [TBL] [Abstract][Full Text] [Related]
19. Advances in combating fungal diseases: vaccines on the threshold. Cutler JE; Deepe GS; Klein BS Nat Rev Microbiol; 2007 Jan; 5(1):13-28. PubMed ID: 17160002 [TBL] [Abstract][Full Text] [Related]
20. Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection. Holanda RA; Muñoz JE; Dias LS; Silva LBR; Santos JRA; Pagliari S; Vieira ÉLM; Paixão TA; Taborda CP; Santos DA; Bruña-Romero O PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005927. PubMed ID: 28938005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]